Profile data is unavailable for this security.
About the company
Ocumension Therapeutics is a China-based holding company principally involved in the discovering, developing and commercializing ophthalmic therapies. Its main products include OT-401 (YUTIQ), OT-1001 (ZERVIATE), OT-502 (DEXYCU), OT-301 (NCX 470), OT-101 and OT-202, among others. The Company conducts its businesses in the domestic market.
- Revenue in HKD (TTM)265.32m
- Net income in HKD-409.00m
- Incorporated2018
- Employees444.00
- LocationOcumension TherapeuticsNo. 1858 Yinzhongnan RoadGuoxiang Subdistrict, Wuzhong DistrictSUZHOU KY1-1205ChinaCHN
- Websitehttps://www.ocumension.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biocytogen Pharmaceuticals Beijng Co Ltd | 772.06m | -412.41m | 3.22bn | 1.07k | -- | 3.81 | -- | 4.17 | -1.04 | -1.04 | 1.94 | 2.12 | 0.2732 | 16.21 | 5.74 | 724,261.60 | -14.59 | -- | -18.88 | -- | 70.59 | -- | -53.42 | -- | 1.24 | -21.30 | 0.4077 | -- | 34.28 | -- | 36.38 | -- | -- | -- |
| China Isotope & Radiation Corp | 7.15bn | 399.50m | 3.34bn | 3.11k | 8.36 | 0.6607 | 3.09 | 0.4674 | 1.25 | 1.25 | 22.34 | 15.80 | 0.5312 | 4.22 | 1.84 | 2,301,260.00 | 6.21 | 6.57 | 12.82 | 13.26 | 52.48 | 59.89 | 11.70 | 12.62 | 1.73 | -- | 0.1919 | 28.27 | 7.82 | 15.35 | -5.43 | 2.88 | 3.63 | 2.92 |
| CK Life Sciences Intl (Holdings) Inc | 5.32bn | 17.25m | 3.41bn | 1.93k | 198.32 | 0.8145 | 30.10 | 0.641 | 0.0018 | 0.0018 | 0.5538 | 0.4359 | 0.4728 | 2.96 | 4.74 | 2,755,038.00 | 0.1532 | 1.11 | 0.211 | 1.43 | 30.76 | 30.52 | 0.3241 | 2.42 | 0.8512 | 0.8796 | 0.5861 | 59.00 | 0.8936 | 0.3407 | -86.93 | -42.01 | 0.2784 | -- |
| CARsgen Therapeutics Holdings Ltd | 0.00 | -805.32m | 3.55bn | 516.00 | -- | 1.83 | -- | -- | -1.45 | -1.45 | 0.00 | 3.37 | 0.00 | -- | -- | 0.00 | -29.79 | -- | -32.14 | -- | -- | -- | -- | -- | 9.54 | -- | 0.0452 | -- | -- | -- | 16.19 | -- | -- | -- |
| Beijing Luzhu Biotechnology Co Ltd | 0.00 | -268.53m | 4.09bn | 133.00 | -- | 3.72 | -- | -- | -1.34 | -1.34 | 0.00 | 5.43 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 6.41 | -- | 0.0185 | -- | -- | -- | 65.62 | -- | -- | -- |
| Jiangsu Recbio Technology Co Ltd | 0.00 | -615.96m | 4.37bn | 472.00 | -- | 3.76 | -- | -- | -1.28 | -1.28 | 0.00 | 2.41 | 0.00 | -- | -- | 0.00 | -25.47 | -- | -30.68 | -- | -- | -- | -- | -- | 2.33 | -- | 0.378 | -- | -- | -- | 20.86 | -- | -- | -- |
| Microport NeuroTech Ltd | -100.00bn | -100.00bn | 4.38bn | 571.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 21.61 | -- | 768.73 | -- | -- | -- |
| Ocumension Therapeutics | 265.32m | -409.00m | 4.69bn | 444.00 | -- | 1.49 | -- | 17.67 | -0.6303 | -0.6303 | 0.4087 | 4.55 | 0.078 | 3.61 | 2.12 | 597,566.70 | -12.03 | -38.78 | -13.21 | -41.47 | 58.60 | 62.30 | -154.16 | -975.82 | 3.72 | -- | 0.0451 | -- | 54.99 | -- | 5.68 | -- | 319.66 | -- |
| Shandong Boan Biotechnology Co Ltd | 665.68m | -128.56m | 4.70bn | 813.00 | -- | 3.30 | -- | 7.05 | -0.2524 | -0.2524 | 1.31 | 2.79 | 0.2732 | 1.35 | 2.53 | 818,795.40 | -5.28 | -- | -7.02 | -- | 66.16 | -- | -19.31 | -- | 0.8383 | -7.47 | 0.2491 | -- | 19.80 | -- | 64.02 | -- | -- | -- |
| Consun Pharmaceutical Group Ltd | 2.79bn | 844.89m | 4.80bn | 3.13k | 5.39 | 1.18 | 5.16 | 1.72 | 1.06 | 1.06 | 3.49 | 4.82 | 0.4981 | 2.08 | 10.05 | 892,027.00 | 15.13 | 12.04 | 22.57 | 19.25 | 74.19 | 74.55 | 30.37 | 24.89 | 2.62 | -- | 0.1155 | 40.84 | 10.71 | 7.03 | 14.88 | 11.01 | -22.93 | 18.43 |
| Sihuan Pharmaceutical Holdings Group Ltd | 2.00bn | -58.17m | 5.22bn | 2.87k | -- | 1.09 | -- | 2.61 | -0.0063 | -0.0063 | 0.2155 | 0.5116 | 0.1572 | 0.8101 | 4.72 | 697,655.80 | -2.18 | -6.85 | -3.34 | -9.10 | 69.64 | 75.81 | -13.85 | -36.23 | 1.35 | -2.63 | 0.1863 | -- | -14.70 | -8.60 | 97.23 | -- | 0.9325 | -- |
| Qyuns Therapeutics Co Ltd | 0.00 | -546.81m | 5.35bn | 331.00 | -- | 16.86 | -- | -- | -2.46 | -2.46 | 0.00 | 1.43 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 1.64 | -69.52 | 0.5349 | -- | -- | -- | -70.28 | -- | -- | -- |
| ImmuneOnco Biopharmaceuticls Shanghi Inc | -100.00bn | -100.00bn | 5.46bn | 145.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -28.25 | -- | 5.82 | -- | -- | -- |
| Shanghai Fudan-Zhangjiang Bio-Pharm. Co | 871.49m | 110.05m | 5.78bn | 948.00 | 17.49 | 0.7627 | -- | 6.64 | 0.1069 | 0.1069 | 0.8276 | 2.45 | 0.2852 | 1.44 | 1.62 | 919,288.80 | 3.59 | 7.03 | 4.35 | 9.05 | 91.40 | 92.17 | 12.59 | 17.26 | 3.94 | 568.37 | 0.0062 | 39.16 | -17.50 | 2.78 | -21.28 | -0.6326 | 20.49 | 0.00 |
| New Horizon Health Ltd | 1.47bn | 119.13m | 6.47bn | 1.04k | 59.32 | 2.01 | 41.72 | 4.41 | 0.2384 | 0.2384 | 3.21 | 7.03 | 0.4536 | 2.16 | 2.08 | 1,670,567.00 | 3.67 | -- | 3.99 | -- | 88.74 | -- | 8.10 | -- | 10.50 | -- | 0.1305 | -- | 259.54 | -- | 97.40 | -- | -- | -- |
| Everest Medicines Ltd | 135.62m | -909.43m | 6.58bn | 432.00 | -- | 1.21 | -- | 48.48 | -2.91 | -2.91 | 0.4332 | 16.76 | 0.0203 | 2.25 | 4.57 | 313,934.60 | -13.63 | -30.52 | -15.06 | -33.14 | 72.67 | -- | -670.57 | -5,745.25 | 8.29 | -- | 0.0979 | -- | 884.46 | -- | -241.50 | -- | 4.65 | -- |
Data as of Jun 14 2024. Currency figures normalised to Ocumension Therapeutics's reporting currency: Hong Kong Dollar HKD
15.72%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Temasek Holdings Pte Ltd. (Investment Management)as of 10 May 2024 | 47.19m | 6.80% |
| Capital Research & Management Co. (World Investors)as of 06 Dec 2023 | 34.37m | 4.95% |
| The Vanguard Group, Inc.as of 06 Jun 2024 | 9.36m | 1.35% |
| Capital Research & Management Co. (Global Investors)as of 31 Mar 2024 | 3.97m | 0.57% |
| Zhong Geng Fund Management Co. , Ltd.as of 31 Dec 2023 | 3.13m | 0.45% |
| FIL Investment Management (Hong Kong) Ltd.as of 30 Apr 2024 | 2.60m | 0.38% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2022 | 2.36m | 0.34% |
| E Fund Management Co., Ltd.as of 31 Dec 2023 | 2.14m | 0.31% |
| UBS Asset Management (Hong Kong) Ltd.as of 29 Feb 2024 | 2.04m | 0.29% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 1.89m | 0.27% |
More ▼
Data from 31 Dec 2023 - 13 Jun 2024Source: FactSet Research Systems Inc.
